Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
J Cosmet Dermatol ; 23(2): 510-524, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37658653

ABSTRACT

BACKGROUND: The development of effective cosmetic products for the reduction of the signs of skin aging is a complex process which requires an optimized combination of ingredients and specialized systems to deliver the actives to the skin layers. AIM: To evaluate the tolerance and antiaging clinical efficacy of a cosmetic formulation containing a blend of nanoencapsulated antioxidants: ascorbyl palmitate, resveratrol, tocopherol, caffeine, carnosine, and niacinamide. METHODS: Clinical efficacy was determined by subjective and instrumental analyses of collagen synthesis by fluorescence spectroscopy, by three-dimensional imaging analysis of suborbital edema, and by analysis of skin hydration and sebum content by biophysical techniques-Corneometer® and Sebumeter®. RESULTS: The studied formulation was safe and effective for the improvement of skin appearance by increasing collagen synthesis and skin moisturizing and by reducing facial blemishes, swelling, and oiliness. A preclinical exploratory approach using an experimental model of human cell and skin cultures agreed with the observed antiaging effects, identifying mechanisms related to the containment of oxidative stress, reduction of melanin production, increased synthesis of type I procollagen, and regulation of the epidermal cohesion protein filaggrin. CONCLUSIONS: The skin benefits obtained resulted from the combination of the ingredients in the formulation and the nanoencapsulation-based delivery system, which favors the solubility, safety, efficacy, and bioavailability of the preparation to the skin.


Subject(s)
Cosmetics , Skin Aging , Humans , Antioxidants/chemistry , Skin , Skin Care , Cosmetics/pharmacology , Cosmetics/chemistry , Collagen/metabolism
2.
PLoS One ; 18(12): e0295624, 2023.
Article in English | MEDLINE | ID: mdl-38117795

ABSTRACT

Exploring alternative fertilizers is crucial in agriculture due to the cost and environmental impact of inorganic options. This study investigated the potential of sewage-derived biofertilizers on the growth and physiology of Amaranthus cruentus plants. Various treatments were compared, including control treatments with inorganic fertilizer and treatments with biofertilizers composed of microalgae, biosolids and reclaimed water. The following traits were investigated: photosynthetic pigments, gas exchange, growth, and leaf nutrient concentrations. The results showed that the concentrations of N, P, Cu, Fe Zn and Na nutrients, in the dry microalgae and biosolids, were quite high for the needs of the plants. The wet microalgae presented high concentration of Cu, Fe and Zn nutrients while reclaimed water contained high concentration of N, K, Ca and S. Na and Zn nutrients increased in the leaf of plants treated with dry microalgae and biosolid, respectively. At the beginning of the flowering phase, total chlorophyll and carotenoids contents were lower for plants grown with wet microalgae while for plants grown with higher doses of biosolid or reclaimed water total chlorophyll was increased, and carotenoids were not affected. Lower photosynthetic pigments under wet microalgae resulted in lower photosynthetic rates. On the other hand, amendments with dry microalgae and biosolid increased photosynthetic rates with the biosolid being the most effective. Higher applications of biosolid, wet and dry microalgae produced a considerable increase in shoot biomass of amaranth, with the dry microalgae being the most effective. Additionally, reclaimed water obtained after tertiary treatment of sewage with microalgae and biosolids applied alone showed promising effects on plant growth. Overall, these findings suggest that organic fertilizers derived from sewage treatment have the potential to enhance plant growth and contribute to sustainable agricultural practices.


Subject(s)
Amaranthus , Water Purification , Sewage , Biosolids , Fertilizers , Plants , Minerals , Nutrients , Water , Carotenoids , Chlorophyll
3.
Pharmaceuticals (Basel) ; 16(4)2023 Apr 05.
Article in English | MEDLINE | ID: mdl-37111303

ABSTRACT

Unsuccessful anesthesia often occurs under an inflammatory tissue environment, making dentistry treatment extremely painful and challenging. Articaine (ATC) is a local anesthetic used at high (4%) concentrations. Since nanopharmaceutical formulations may improve the pharmacokinetics and pharmacodynamics of drugs, we encapsulated ATC in nanostructured lipid carriers (NLCs) aiming to increase the anesthetic effect on the inflamed tissue. Moreover, the lipid nanoparticles were prepared with natural lipids (copaiba (Copaifera langsdorffii) oil and avocado (Persia gratissima) butter) that added functional activity to the nanosystem. NLC-CO-A particles (~217 nm) showed an amorphous lipid core structure according to DSC and XDR. In an inflammatory pain model induced by λ-carrageenan in rats, NLC-CO-A improved (30%) the anesthetic efficacy and prolonged anesthesia (3 h) in relation to free ATC. In a PGE2-induced pain model, the natural lipid formulation significantly reduced (~20%) the mechanical pain when compared to synthetic lipid NLC. Opioid receptors were involved in the detected analgesia effect since their blockage resulted in pain restoration. The pharmacokinetic evaluation of the inflamed tissue showed that NLC-CO-A decreased tissue ATC elimination rate (ke) by half and doubled ATC's half-life. These results present NLC-CO-A as an innovative system to break the impasse of anesthesia failure in inflamed tissue by preventing ATC accelerated systemic removal by the inflammatory process and improving anesthesia by its association with copaiba oil.

4.
Int J Pharm ; 634: 122672, 2023 Mar 05.
Article in English | MEDLINE | ID: mdl-36738810

ABSTRACT

Etidocaine (EDC) is a long-acting local anesthetic of the aminoamide family whose use was discontinued in 2008 for alleged toxicity issues. Ionic gradient liposomes (IGL) are nanostructured carriers for which an inner/outer gradient of ions increases drug upload. This work describes IGLEDC, a formulation optimized by Design of Experiments, composed of hydrogenated soy phosphatidylcholine:cholesterol:EDC, and characterized by DLS, NTA, TEM/Cryo-TEM, DSC and 1H NMR. The optimized IGL showed significant encapsulation efficiency (41 %), good shelf stability (180 days) and evidence of EDC interaction with the lipid bilayer (as seen by DSC and 1H NMR results) that confirms its membrane permeation. In vitro (release kinetics and cytotoxicity) tests showed that the encapsulation of EDC into the IGL promoted sustained release for 24 h and decreased by 50 % the intrinsic toxicity of EDC to Schwann cells. In vivo IGLEDC decreased the toxicity of EDC to Caenorhabditis elegans by 25 % and extended its anesthetic effect by one hour, after infiltrative administration, at clinically used (0.5 %) concentration, in rats. Thus, this novel drug delivery system is a promise for the possible reintroduction of EDC in clinics, aiming at the control of operative and postoperative pain.


Subject(s)
Anesthesia , Liposomes , Rats , Animals , Liposomes/chemistry , Etidocaine , Anesthetics, Local , Ions/chemistry
5.
Molecules ; 27(24)2022 Dec 13.
Article in English | MEDLINE | ID: mdl-36557969

ABSTRACT

Breast cancer is the neoplasia of highest incidence in women worldwide. Docetaxel (DTX), a taxoid used to treat breast cancer, is a BCS-class-IV compound (low oral bioavailability, solubility and intestinal permeability). Nanotechnological strategies can improve chemotherapy effectiveness by promoting sustained release and reducing systemic toxicity. Nanostructured lipid carriers (NLC) encapsulate hydrophobic drugs in their blend-of-lipids matrix, and imperfections prevent drug expulsion during storage. This work describes the preparation, by design of experiments (23 factorial design) of a novel NLC formulation containing copaiba oil (CO) as a functional excipient. The optimized formulation (NLCDTX) showed approximately 100% DTX encapsulation efficiency and was characterized by different techniques (DLS, NTA, TEM/FE-SEM, DSC and XRD) and was stable for 12 months of storage, at 25 °C. Incorporation into the NLC prolonged drug release for 54 h, compared to commercial DTX (10 h). In vitro cytotoxicity tests revealed the antiproliferative effect of CO and NLCDTX, by reducing the cell viability of breast cancer (4T1/MCF-7) and healthy (NIH-3T3) cells more than commercial DTX. NLCDTX thus emerges as a promising drug delivery system of remarkable anticancer effect, (strengthened by CO) and sustained release that, in clinics, may decrease systemic toxicity at lower DTX doses.


Subject(s)
Antineoplastic Agents , Breast Neoplasms , Nanoparticles , Nanostructures , Oils, Volatile , Female , Humans , Docetaxel/pharmacology , Docetaxel/therapeutic use , Breast Neoplasms/drug therapy , Antineoplastic Agents/chemistry , Delayed-Action Preparations/therapeutic use , Drug Carriers/chemistry , Nanostructures/chemistry , Oils, Volatile/therapeutic use , Particle Size , Nanoparticles/chemistry
6.
Food Chem ; 394: 133503, 2022 Nov 15.
Article in English | MEDLINE | ID: mdl-35728472

ABSTRACT

This study aimed to produce and characterized active biodegradable packages by extrusion of cassava starch, biodegradable polyester, plasticizer, and acai extract (EA 0, 1, 2, 3 and 4%) and to evaluate its effects on extra virgin olive oil (EVOO) for 120 days. All analyses were performed at the beginning (day 0) and the end of the experiment (day 120). The oil was characterized for acidity index (IA), peroxide index (IP), thiobarbituric acid reactive substances (TBARS), conjugated dienes (CD), phenolic compounds (PC) and color parameters. The incorporation of EA at the initial time caused increased thickness, mechanical properties, solubility in water and oil in all formulations. The some values of properties increased or decreased, due to the interaction of the stored product and packaging. At the end of the storage period, the values of IA and IP were below the limits established by current legislation. The EVOO showed a gradual decrease in PC from day 1 to day 120, for all treatments.


Subject(s)
Euterpe , Olive Oil/analysis , Phenols/analysis , Plant Extracts , Starch
7.
Rev. colomb. ciencias quim. farm ; 51(1)ene.-abr. 2022.
Article in English | LILACS-Express | LILACS | ID: biblio-1535815

ABSTRACT

SUMMARY Introduction: Carthamus oil is a compound that has the potential to be used in numerous applications due to its anti-inflammatory, antioxidant, immunomodulatory and neuroprotective effects. Chromium picolinate has been indicated for the control of insulin resistance. Aim: To evaluate the effect of Carthamus oil (30 mg/kg) and chromium picolinate (5 µg/kg) interaction with oral glyburide in chemically diabetes-induced Wistar rats and its influence on drug therapy. Method: Diabetes mellitus was induced with streptozotocin, and the animals were randomized into experimental groups (n= 6/group), who received gastric gavage treatments for ten days, G1: control, G2: diabetic and received glyburide, G3: diabetic and received the interaction of Carthamus oil and chromium picolinate, G4: diabetic and received the interaction ofglyburide, Carthamus oil and chromium picolinate. After the treatment period, fasting blood glucose, post-sucrose blood glucose, total cholesterol and triglyceride levels, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in blood serum were compared, in addition to urine analysis. Results: In this study, the only altered parameters were the post-sucrose blood glucose measurement with the lowest result for G4 (P <0.05) and the ALT measurement, with lower values for G4 (P <0.05) compared to G1. Conclusion: It can be concluded that the unprecedented interaction of Carthamus oil, chromium picolinate and glyburide contributed to the reduction of blood glucose and serum levels of ALT in diabetic rats and is promising for future studies in humans.


Introdução: o óleo de cártamo (Carthamus oil) tem sido utilizado em diversas aplicações devido suas ações antiinflamatória, antioxidante, imunomoduladora e neuro protetora. O picolinato de cromo tem sido indicado para o controle da resistência à insulina. Objetivo: avaliar o efeito da interação de óleo de cártamo (30 mg/kg) e picolinato de cromo (5 µg/kg) com glibenclamida em ratos com diabetes induzida. Metodologia: a indução de diabetes mellitus foi realizada com injeção intra-peritoneal de estreptozotocina e os animais foram aleatoriamente distribuidos em grupos experimentais (n= 6/grupo), que receberam os tratamentos por gavagem gástrica durante dez dias, G1: controle, G2: grupo diabético que recebeu gliben-clamida, G3: grupo diabético que recebeu óleo de cártamo e picolinato de cromo, G4: grupo diabético que recebeu glibenclamida, óleo de cártamo e picolinato de cromo. Após os dias de tratamento via oral, determinou-se o peso corpóreo, glicemia de jejum, colesterol total, triglicerideos, glicemia após uma hora de gavagem gástrica com sacarose, transaminases hepáticas e a avaliação da urina. Resultados: a análise estatistica dos dados indicou que os únicos parâmetros alterados foram a glicemia após a ingestão de sacarose, os menores valores obtidos foram em G4 (P <0.05) e a redução dos niveis séricos de ALT em G4 (P <0.05) quando comparados com G1. Conclusão: a interação inédita do óleo de cártamo, picolinato de cromo e glibencla-mida contribuiu para a redução da glicose sanguinea e dos niveis séricos de ALT em ratos diabéticos, é promissora para estudos futuros em humanos.


Introducción: el aceite de cártamo (Carthamus oil) se ha utilizado en diversas aplicaciones debido a sus propiedades antiinflamatorias, antioxidantes, inmunomodu-ladoras y neuroprotectoras. El picolinato de cromo ha sido indicado para el control de la resistencia a la insulina. Objetivo: evaluar el efecto de la interacción de aceite de cártamo (30 mg/kg) y picolinato de cromo (5 µg/kg) con glibenclamida en ratas con diabetes inducida. Metodología: la inducción de diabetes mellitus se realizó con inyección intraperitoneal de estreptozotocina y los animales se distribuyeron aleatoriamente en grupos experimentales (n= 6/grupo), los cuales recibieron tratamientos por sonda gástrica durante diez dias, G1: control, G2: grupo diabético que recibieron glibenclamida, G3: grupo diabético que recibió aceite de cártamo y picolinato de cromo, G4: grupo diabético que recibió glibenclamida, aceite de cártamo y picolinato de cromo. Después de los dias de tratamiento oral, se determinó peso corporal, glucosa en ayunas, colesterol total, triglicéridos, glucosa después de una hora de sonda gástrica con sacarosa, transaminasas hepáticas y evaluación de orina. Resultados: el análisis estadistico de los datos indicó que los únicos parámetros alterados fueron la glucosa en sangre después de la ingesta de sacarosa, los valores más bajos obtenidos fueron en G4 (P <0,05) y la reducción de los niveles séricos de ALT en G4 (P <0,05) cuando en comparación con G1. Conclusión: la interacción sin precedentes del aceite de cártamo, el picolinato de cromo y la glibenclamida contribuyó a la reducción de los niveles de glucosa en sangre y ALT sérica en ratas diabéticas, es prometedora para futuros estudios en humanos.

8.
Pharmaceutics ; 14(3)2022 Mar 08.
Article in English | MEDLINE | ID: mdl-35335959

ABSTRACT

The oral administration of the anti-inflammatory indomethacin (INDO) causes severe gastrointestinal side effects, which are intensified in chronic inflammatory conditions when a continuous treatment is mandatory. The development of hybrid delivery systems associates the benefits of different (nano) carriers in a single system, designed to improve the efficacy and/or minimize the toxicity of drugs. This work describes the preparation of hybrid nanobeads composed of nanostructured lipid carriers (NLC) loading INDO (2%; w/v) and chitosan, coated by xanthan. NLC formulations were monitored in a long-term stability study (25 °C). After one year, they showed suitable physicochemical properties (size < 250 nm, polydispersity < 0.2, zeta potential of −30 mV and spherical morphology) and an INDO encapsulation efficiency of 99%. The hybrid (lipid-biopolymers) nanobeads exhibited excellent compatibility between the biomaterials, as revealed by structural and thermodynamic properties, monodisperse size distribution, desirable in vitro water uptake and prolonged in vitro INDO release (26 h). The in vivo safety of hybrid nanobeads was confirmed by the chicken embryo (CE) toxicity test, considering the embryos viability, weights of CE and annexes and changes in the biochemical markers. The results point out a safe gastro-resistant pharmaceutical form for further efficacy assays.

9.
Surg. cosmet. dermatol. (Impr.) ; 14: e20220118, jan.-dez. 2022.
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1398975

ABSTRACT

Introdução: extratos vegetais e ativos derivados de plantas tem sido desenvolvidos com o objetivo de melhorar e potencializar o processo de cicatrização cutânea, dentre eles, o Triticum aestivum L. (sinônimo Triticum vulgare). Objetivo: avaliar o efeito do extrato de grão inteiro (EGTA-PR) e extrato aquoso (EATA-FI) de Triticum aestivum L. na cicatrização cutânea em pele humana ex vivo. Métodos: fragmentos de pele obtidos de cirurgia plástica eletiva foram submetidos a lesões teciduais e tratados com os extratos durante oito dias para avaliação histológica da reepitelização e marcação proteica do fator de crescimento epidérmico (EGF). Resultados: EGTA-PR e EATA-FI aceleraram o processo de reepitelização em cultura de pele humana submetida a lesão tecidual. Adicionalmente, foi observado um aumento da marcação proteica de EGF após o tratamento com EGTA-PR. Conclusão: EGTA-PR apresentou um melhor desempenho na reepitelização quando comparado ao EATA-FI, pois apresentou uma maior marcação proteica para EGF em cultura de pele humana. Da mesma forma, os resultados histológicos mostraram que a redensificação dérmica obtida com o EGTA-PR foi visualmente superior à observada com EATA-FI. Os resultados obtidos são promissores e corroboram as diversas ações biológicas já reportadas na literatura para extrato de Triticum aestivum L. nas etapas da cicatrização tecidual.


Introduction: Plant extracts and actives derived from plants were developed to improve and enhance the skin healing process including Triticum aestivum L. (Triticum vulgare). Purpose: To evaluate the effect of whole grain extract (EGTA-PR) and aqueous extract (EATA-FI) of Triticum aestivum L., on ex vivo skin healing. Methods: Skin fragments obtained from elective plastic surgery were subjected to tissue damage and treated with extracts for eight days for histological evaluation of re-epithelialization and immunofluorescence for epidermal growth factor (EGF). Results: EGTA-PR and EATA-FI accelerated the re-epithelialization process in human skin culture submitted to tissue injury. Additionally, we observed increased EGF protein labeling after treatment with EGTA-PR. Conclusion: EGTA-PR showed a better performance in re-epithelialization when compared to EATA-FI, as it presented a higher protein labeling for EGF in human skin culture. Likewise, the histological results showed that the dermal redensification obtained with EGTA-PR was visually superior to that observed with EATA-FI. The results obtained are promising and corroborate the several biological actions already reported in the literature for Triticum aestivum L. extract in tissue healing stages

10.
Water Sci Technol ; 84(12): 3469-3488, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34928820

ABSTRACT

A DEWATS (decentralized wastewater treatment system) is an alternative for expanding sanitation. In Brazil, DEWATS is acknowledged by law and is part of the National Sanitation Plan strategy for achieving the treatment of 85.6% of all the generated wastewater by 2033, improving the current treatment index of 49%. This review's aim is to identify DEWATS studies in Brazil and to verify their potential for narrowing the national wastewater treatment deficit. Hence, aspects such as cost, maintenance, and efficiency were assessed. The archival research method (ARM) was used to identify papers published in the last 20 years through the scientific databases of Scopus, Science Direct, and Web of Science. Data regarding the general characteristics of each study were collected and compared to Brazilian environmental regulation and sanitation status. The results showed the evaluation of different technologies such as DEWATS, highlighting their flexibility and potential use in 79% of Brazilian counties. However, although 81% of the studies conducted performance analysis, none covered the main parameters required by Brazilian law. Although legal gaps for DEWATS improvement and consolidation have been identified and the interest in studying DEWATS has been increasing in the last five years, many barriers to their widespread use remain.


Subject(s)
Wastewater , Water Purification , Brazil , Research/trends
11.
Molecules ; 26(22)2021 Nov 17.
Article in English | MEDLINE | ID: mdl-34834022

ABSTRACT

Ideally, antineoplastic treatment aims to selectively eradicate cancer cells without causing systemic toxicity. A great number of antineoplastic agents (AAs) are available nowadays, with well-defined therapeutic protocols. The poor bioavailability, non-selective action, high systemic toxicity, and lack of effectiveness of most AAs have stimulated the search for novel chemotherapy protocols, including technological approaches that provide drug delivery systems (DDS) for gold standard medicines. Nanostructured lipid carriers (NLC) are DDS that contain a core of solid and lipid liquids stabilised by surfactants. NLC have high upload capacity for lipophilic drugs, such as the majority of AAs. These nanoparticles can be prepared with a diversity of biocompatible (synthetic or natural) lipid blends, administered by different routes and functionalised for targeting purposes. This review focused on the research carried out from 2000 to now, regarding NLC formulations for AAs (antimetabolites, antimitotics, alkylating agents, and antibiotics) encapsulation, with special emphasis on studies carried out in vivo. NLC systems for codelivery of AAs were also considered, as well as those for non-classical drugs and therapies (natural products and photosensitisers). NLC have emerged as powerful DDS to improve the bioavailability, targeting and efficacy of antineoplastics, while decreasing their toxic effect in the treatment of different types of cancer.


Subject(s)
Antineoplastic Agents , Drug Carriers , Drug Compounding , Lipids , Nanoparticles , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Biological Availability , Drug Carriers/chemical synthesis , Drug Carriers/chemistry , Drug Carriers/pharmacokinetics , Drug Carriers/therapeutic use , Humans , Lipids/chemical synthesis , Lipids/chemistry , Lipids/pharmacokinetics , Lipids/therapeutic use , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Particle Size , Surface-Active Agents/chemistry
12.
Altern Lab Anim ; 49(4): 137-146, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34399588

ABSTRACT

Native human skin has been reported in the literature as being an important experimental model for studying skin biology. Studies performed by our group have shown that ex vivo skin, from elective plastic surgery, maintains the biological characteristics of native skin under specific culture conditions. As such, it might be a feasible model for the safety and efficacy testing of topical substances. While Brazil is at the forefront of global regulation implementation, Brazilian researchers are not always able to transfer certain widely used protocols to their laboratories, particularly protocols that involve the use of reconstructed tissues with limited viability, such as those for skin corrosion (OECD TG 431) and irritation testing (OECD TG 439). In this study, we investigated the applicability of the ex vivo skin model to the evaluation of irritation and corrosion potential of a number of proficiency substances described in TG 431 and TG 439. The skin fragments were standardised in size and diameter, and placed into cell culture inserts. The experimental protocol was conducted according to TG 431 and TG 439. The results obtained show that ex vivo skin could represent a promising tool for the evaluation of irritation and corrosion potential of substances (subject to inclusion and exclusion criteria), as recommended by OECD guidelines. While this is a proof-of-concept study, the use of ex vivo skin should be considered for such testing.


Subject(s)
Irritants , Skin Irritancy Tests , Animal Testing Alternatives , Animals , Corrosion , Humans , Irritants/toxicity , Skin
13.
Int J Pharm ; 606: 120944, 2021 Sep 05.
Article in English | MEDLINE | ID: mdl-34324985

ABSTRACT

Bupivacaine is the most employed local anesthetic in surgical procedures, worldwide. Its systemic toxicity has directed the synthesis of the less toxic, S(-) enantiomer. This work describes a formulation of ionic gradient liposomes (IGL) containing S75BVC, an enantiomeric excess mixture of 75% S(-) and 25% R(+) bupivacaine. IGL prepared with 250 mM (NH4)2SO4 in the inner aqueous core of phosphatidylcholine and cholesterol (3:2 mol%) vesicles plus 0.5% S75BVC showed average sizes of 312.5 ± 4.5 nm, low polydispersity (PDI < 0.18), negative zeta potentials (-14.2 ± 0.2 mV) and were stable for 360 days. The encapsulation efficiency achieved with IGLS75BVC (%EE = 38.6%) was higher than with IGL prepared with racemic bupivacaine (IGLRBVC, %EE = 28.3%). TEM images revealed spherical vesicles and µDSC analysis provided evidence on the interaction of the anesthetic with the lipid bilayer. Then, in vitro - release kinetics and cytotoxicity- and in vivo - toxic effects in Zebrafish and biochemical/histopathological analysis plus analgesia in Wistar rats - tests were performed. IGLS75BVC exhibited negligible toxicity against Schwann cells and Zebrafish larvae, and it did not affect biochemical markers or the morphology of rat tissues (heart, brain, cerebellum, sciatic nerve). The in vitro release of S75BVC from IGL was extended from 4 to 24 h, justifying the prolonged anesthetic effect measured in rats (~9 h). The advantages of IGLS75BVC formulation over IGLRBVC and plain bupivacaine formulations (prolonged anesthesia, preferential sensorial blockade, and no toxicity) confirm its potential for clinical use in surgical anesthesia.


Subject(s)
Anesthesia , Bupivacaine , Anesthetics, Local/toxicity , Animals , Bupivacaine/toxicity , Liposomes , Rats , Rats, Wistar , Zebrafish
14.
J Cosmet Dermatol ; 20(1): 360-365, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32433801

ABSTRACT

BACKGROUND: Excessive androgenesis in the skin promotes sebaceous hyperproduction which is the onset of acne vulgaris pathogenesis. Free fatty acids and lipid accumulation in the glandular infundibulum culminates in microbiota imbalance, triggering inflammatory response and follicular hyperkeratinization. AIMS: The purpose of this work was to present an alternative cosmetic treatment for acne skin care, focusing on the prevention of sebaceous gland dysregulation. METHODS: Insulin-stimulated human sebocytes were treated with noncytotoxic concentrations of a DTRW cosmetic formulation. After 6 days of incubation, cell lysates were collected for testosterone, 5α-reductase, and dyhidrotestosterone (DHT) quantitation. In parallel, cells were stained with Oil Red O to measure sebum production. RESULTS: Human sebocytes were incubated with insulin to mimic a seborrheic microenvironment with overproduction of intracellular lipids and fatty acids. Concomitant incubation of cell cultures with DRTW was able to promote a 52.97% reduction in intracellular lipid content. The anti-androgenic properties of DRTW had been proved by the reductions of testosterone (↓59.90%), 5α reductase (↓59.34%), and DHT (↓55.98%) levels in sebocyte cultures also stimulated with insulin. CONCLUSION: The results indicate a promising action of DRTW cosmetic formulation in preventing the development of acne lesions by mechanisms involving the modulation of cutaneous androgenesis and consequently the control of sebum overproduction, considered one of the leading causes of acne.


Subject(s)
Acne Vulgaris , Sebum , Acne Vulgaris/drug therapy , Androgens , Humans , Sebaceous Glands , Skin
15.
J Cosmet Dermatol ; 20(7): 2179-2189, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33179848

ABSTRACT

BACKGROUND: Mechanisms involved in hair metabolism are diverse, and the availability of ingredients that normalize dysfunctions or mitigate the effects of extrinsic stress suffered daily is greatly desired by consumers to improve the aesthetic appearance of hair. AIMS: In this work, we carried out a preclinical exploratory approach to evaluate the effects of a complex of nanoencapsulated active ingredients (AcPi), as well as a cosmetic formulation containing AcPi (ShPi and HtPi) in mechanisms involving hair loss and follicular aging. METHODS: Human hair follicle dermal papilla cells and human scalp culture were treated with AcPi, ShPi, or HtPi and stimulated with UV radiation or testosterone for further measurement of mitochondrial biogenesis, reactive oxygen species (ROS), ß-catenin, dyhidrotestosterone (DHT), collagen XVIIα1 (COL17A1), and cutaneous permeation. RESULTS: Our results demonstrated that AcPi prevents oxidative stress and balances mitochondial activity disturbed by exposure to UV radiation. AcPi also promoted an enrichment of WNT/ß-catenin signaling pathway, stimulating hair growth, and lengthening the anagen phase of hair cycle. ShPi and HtPi were able to prevent hair aging, minimizing the excessive degradation of COL17A1 in hair follicle exposed to UV radiation, in addition to controlling androgenic metabolism by reducing DHT production. CONCLUSION: The integral effects of AcPi have not been completely elucidated; however, these results, associated with clinical evidences, allow us to infer that this ingredient prevents follicular aging, miniaturization, and consequently hair loss by mechanisms involving energetic homeostasis maintenance, antioxidant, and anti-androgenic actions.


Subject(s)
Hair Follicle , Wnt Signaling Pathway , Aging , Alopecia/prevention & control , Hair Follicle/metabolism , Humans , Stem Cells/metabolism , beta Catenin/metabolism
16.
Rev. colomb. ciencias quim. farm ; 49(1): 5-16, Jan.-Apr. 2020. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1144335

ABSTRACT

SUMMARY Food supplements are easily acquired and used in various countries. Silymarin has been indicated for diseases of the liver and Chromium picolinate has been indicated for body weight loss and for the improvement of glycemic index. The objective of the present study was to assess the effects of short-term treatment with a combination of silymarin (50 mg/kg) and chromium picolinate (5 µg/kg) on the standard glibenclamide treatment (10 mg/kg) of rats with induced diabetes. DM2 was induced with streptozotocin. Experimental groups of rats: healthy control group, glibenclamide diabetic group, silymarin diabetic group, and silymarin, chromium picolinate and glibenclamide group. After 10 days of oral treatment, we determined body weight, fasting glycemia, glycemia 1 h after gastric gavage with sucrose, and AST and ALT transaminases. Statistical analysis of the data indicated that there was no change in body weight or fasting glycemia, but that glycemia increased after gavage with sucrose in the group submitted to combined therapy. Thus, we concluded that the combination of silymarin and chromium picolinate reduced the efficacy of glibenclamide in the short term, although the two substances had a protective effect on the liver as observed by the reduction of blood transaminase levels.


RESUMO Suplementos alimentares são de fácil aquisição e uso em diversos países. A silimarina tem sido indicada para desordens hepáticas e o picolinato de cromo tem sido utilizado para perda de peso corporal e melhoria do índice glicêmico. O objetivo deste trabalho foi avaliar os efeitos do tratamento utilizando uma combinação de silimarina (50 mg/kg) e picolinato de cromo (5 µg/kg) sobre o tratamento com glibencla-mida (10 mg/kg) em ratos com diabetes induzida com estreptozotocina. Os grupos experimentais foram: grupo controle sadio, grupo diabético glibenclamida, grupo diabético silimarina e grupo diabético silimarina, picolinato de cromo e glibencla-mida. Após 10 dias de tratamento via oral, determinou-se o peso corpóreo, glicemia de jejum, glicemia após uma hora de gavagem gástrica com sacarose e transaminases hepáticas. A análise estatística dos dados indicou que não ocorreu alteração significativa no peso corpóreo e na glicemia de jejum, mas ocorreu aumento significativo dos níveis glicêmicos no grupo diabético silimarina, picolinato de cromo e glibenclamida após a gavagem com sacarose no grupo com a terapia combinada. Portanto, conclui-se que a combinação utilizada reduziu a eicácia da glibenclamida em curto prazo, embora ambas substancias tenham exibido efeito hepatoprotetor, observado pela redução dos níveis plasmáticos de transaminases.

17.
Water Environ Res ; 91(12): 1678-1691, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31251422

ABSTRACT

In order to assist with the management of water resources, this study aimed to calibrate the water quality model "Ottocoded Critical Basins Analysis" (ABaCO) in a section of the Lambari River, located in the city of Poços de Caldas, Minas Gerais, Brazil, and it is considered qualitatively critical by the "National Water Agency" (ANA). The calibration results, obtained automatically by the Microsoft Excel® tool Solver, showed good adjustments between the simulated and observed concentrations for the following parameters: total nitrogen, organic phosphorus, inorganic phosphorus, and total phosphorus, considering a visual interpretation of the graphics. The other calibrated parameters (BOD, DO, organic nitrogen, ammoniacal nitrogen, and nitrate) obtained satisfactory adjustments. When evaluating the results by coefficient of determination, it was observed that all parameters showed negative values to one or more field campaigns. However, the calibrated values of the parameters can be incorporated into the model to obtain a first view of the river's qualitative situation, aiming to plan, control, and protect water resources to assist in decision-making and to favor performance of intervention analyses of environmental control measures. PRACTITIONER POINTS: Calibration of water quality model in a section of a river located in Brazil considered qualitatively critical; The calibration occurred automatically and manually, when it was necessary, in an Excel® spreadsheet, generated from the water quality model; The automation process was performed by the Excel® Solver tool through the objective function; Through visual interpretation, it was noticed that the calibrated parameters were well adjusted to the data observed in the field; Sensitivity analysis showed that the studied parameters did not show significant differences in relation to the values calibrated for parameters.


Subject(s)
Water Pollutants, Chemical , Water Quality , Brazil , Calibration , Cities , Environmental Monitoring , Rivers
18.
Water Environ Res ; 91(9): 898-905, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31004526

ABSTRACT

The scarcity of natural resources supports the perspective of reusing treated effluents, mainly in agriculture, where the reduction in the demand of drinking water and the provision of alternative sources for nutrients are important. However, the process of disinfection, essential to the protection of human health, generates deleterious by-products to both humans and the environment. This research aimed to evaluate the use of ozone as a disinfectant for wastewater treated by anaerobic/aerobic baffled reactor for later agricultural reuse. Disinfection tests were conducted by applying ozone, in batch, with applied dosages of 5, 8, and 10 mg O3 /L and contact time of 7 min. All the tests led to formaldehyde formation, therefore within the standard suggested by the World Health Organization. For the indicators total coliforms and Escherichia coli, the ozone was considered effective, satisfying the criteria for agricultural reuse according to the World Health Organization of a dosage of 8 mg O3 /L. PRACTITIONER POINTS: Proposal of decentralized system (anaerobic/aerobic baffled reactor + ozone disinfection) for effluent treatment for agricultural reuse. Formation of formaldehyde dependent on applied ozone dose. Demand of ozone consumed preferentially for the formation of by-products, with low removal of COD. High formaldehyde formation (high ozone demand) can impair the inactivation of pathogens. System promotes effluent that meets the standards established by the World Health Organization (WHO) for agricultural reuse.


Subject(s)
Ozone , Water Purification , Anaerobiosis , Disinfection , Formaldehyde , Humans , Water Microbiology
19.
Water Sci Technol ; 80(8): 1505-1511, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31961813

ABSTRACT

Decentralized sanitary wastewater treatment has become a viable and sustainable alternative, especially for developing countries and small communities. Besides, effluents may present variations in chemical oxygen demand (COD), biochemical oxygen demand (BOD) and total nitrogen values. This study describes the feasibility of using a pilot upflow anaerobic sludge blanket (UASB) reactor to treat wastewater with different organic loads (COD), using black water (BW) and sanitary wastewater, in addition to its potential for preserving nutrients for later recovery and/or reuse. The UASB reactor was operated continuously for 95 weeks, with a hydraulic retention time of 3 days. In Phase 1, the reactor treated simulated BW and achieved 77% CODtotal removal. In Phase 2, treating only sanitary wastewater, the CODtotal removal efficiency was 60%. Phase 3 treated simulated BW again, and CODtotal removal efficiency was somewhat higher than in Phase 1, reaching 81%. In Phase 3, the removal of pathogens was also evaluated: the efficiency was 1.96 log for Escherichia coli and 2.13 log for total coliforms. The UASB reactor was able to withstand large variations in the organic loading rate (0.09-1.49 kg COD m-3 d-1), in continuous operation mode, maintaining a stable organic matter removal.


Subject(s)
Sewage , Water Purification , Anaerobiosis , Bioreactors , Pilot Projects , Waste Disposal, Fluid
20.
Colloids Surf B Biointerfaces ; 175: 56-64, 2019 Mar 01.
Article in English | MEDLINE | ID: mdl-30517905

ABSTRACT

In this work, a stable nanocarrier for the anti-cancer drug docetaxel was rational designed. The nanocarrier was developed based on the solid lipid nanoparticle preparation process aiming to minimize the total amount of excipients used in the final formulations. A particular interest was put on the effects of the polymers in the final composition. In this direction, two poloxoamers -Pluronic F127 and F68- were selected. Some poloxamers are well known to be inhibitors of the P-glycoprotein efflux pump. Additionally, their poly-ethylene-oxide blocks can help them to escape the immune system, making the poloxamers appealing to be present in a nanoparticle designed for the treatment of cancer. Within this context, a factorial experiment design was used to achieve the most suitable formulations, and also to identify the effects of each component on the final (optimized) systems. Two final formulations were chosen with sizes < 250 nm and PDI < 0.2. Then, using dynamic light scattering and nanotracking techniques, the stability of the formulations was assessed during six months. Structural studies were carried on trough different techniques: DSC, x-ray diffraction, FTIR-AR and Molecular Dynamics. The encapsulation efficiency of the anticancer drug docetaxel (> 90%) and its release dynamics from formulations were measured, showing that the polymer-lipid nanoparticle is suitable as a drug delivery system for the treatment of cancer.


Subject(s)
Docetaxel/administration & dosage , Drug Delivery Systems/methods , Lipids/chemistry , Nanoparticles/chemistry , Polymers/chemistry , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacokinetics , Calorimetry, Differential Scanning , Docetaxel/chemistry , Docetaxel/pharmacokinetics , Drug Carriers/chemistry , Drug Design , Drug Liberation , Microscopy, Electron, Transmission , Nanoparticles/ultrastructure , Poloxamer/chemistry , Polyethylene Glycols/chemistry , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL
...